BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 31284804)

  • 1. Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non-Obstructive Coronary Arteries.
    Choo EH; Chang K; Lee KY; Lee D; Kim JG; Ahn Y; Kim YJ; Chae SC; Cho MC; Kim CJ; Kim HS; Jeong MH;
    J Am Heart Assoc; 2019 Jul; 8(14):e011990. PubMed ID: 31284804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Secondary Prevention Medication on the Prognosis in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Abdu FA; Liu L; Mohammed AQ; Xu B; Yin G; Xu S; Xu Y; Che W
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):678-683. PubMed ID: 33284169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Lindahl B; Baron T; Erlinge D; Hadziosmanovic N; Nordenskjöld A; Gard A; Jernberg T
    Circulation; 2017 Apr; 135(16):1481-1489. PubMed ID: 28179398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA): A meta-analysis.
    De Filippo O; Russo C; Manai R; Borzillo I; Savoca F; Gallone G; Bruno F; Ahmad M; De Ferrari GM; D'Ascenzo F
    Int J Cardiol; 2022 Dec; 368():1-9. PubMed ID: 35987312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effect of angiotensin converting enzyme inhibitor versus angiotensin ii type i receptor blocker in acute myocardial infarction with non-obstructive coronary arteries; from the Korea Acute Myocardial Infarction Registry - National Institute of Health.
    Ahn JH; Hyun JY; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Park HS; Kim DI; Hur SH; Oh SK; Ahn Y
    Cardiol J; 2021; 28(5):738-745. PubMed ID: 33001422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines).
    Smilowitz NR; Mahajan AM; Roe MT; Hellkamp AS; Chiswell K; Gulati M; Reynolds HR
    Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):e003443. PubMed ID: 29246884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
    Nakao K; Yasuda S; Nishimura K; Noguchi T; Nakai M; Miyamoto Y; Sumita Y; Shishido T; Anzai T; Ito H; Tsutsui H; Saito Y; Komuro I; Ogawa H
    J Am Heart Assoc; 2019 Apr; 8(7):e009692. PubMed ID: 30909774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries.
    Hjort M; Lindahl B; Baron T; Jernberg T; Tornvall P; Eggers KM
    Am Heart J; 2018 Jun; 200():60-66. PubMed ID: 29898850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial infarction with nonobstructive coronary arteries: a single-center retrospective study.
    Montenegro Sá F; Ruivo C; Santos LG; Antunes A; Saraiva F; Soares F; Morais J
    Coron Artery Dis; 2018 Sep; 29(6):511-515. PubMed ID: 29608443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Late Cardiac Death and Myocardial Infarction Rates in Women Vs Men With ST-Elevation Myocardial Infarction.
    Burgess SN; Juergens CP; Nguyen TL; Leung M; Robledo KP; Thomas L; Mussap CJ; Zaman SJ; Lo STH; French JK
    Am J Cardiol; 2020 Aug; 128():120-126. PubMed ID: 32650905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinfarction in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Coronary Findings and Prognosis.
    Nordenskjöld AM; Lagerqvist B; Baron T; Jernberg T; Hadziosmanovic N; Reynolds HR; Tornvall P; Lindahl B
    Am J Med; 2019 Mar; 132(3):335-346. PubMed ID: 30367850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
    Gitsels LA; Kulinskaya E; Steel N
    BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries.
    Eggers KM; Hjort M; Baron T; Jernberg T; Nordenskjöld AM; Tornvall P; Lindahl B
    J Intern Med; 2019 Apr; 285(4):419-428. PubMed ID: 30474313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
    Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease.
    Paolisso P; Bergamaschi L; Saturi G; D'Angelo EC; Magnani I; Toniolo S; Stefanizzi A; Rinaldi A; Bartoli L; Angeli F; Donati F; Rucci P; Mattioli AV; Taglieri N; Pizzi C; Galiè N
    Front Pharmacol; 2019; 10():1606. PubMed ID: 32082147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial infarction without obstructive coronary artery disease (MINOCA) - prevalence and prognosis].
    Jánosi A; Ferenci T; Kőszegi Z; Nagy GG; Jambrik Z; Ruzsa Z; Lupkovics G; Csanádi Z; Becker D; Merkely B; Andréka P
    Orv Hetil; 2019 Nov; 160(45):1791-1797. PubMed ID: 31680539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
    Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI;
    Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Arnott C; Delatour V; Leósdóttir M; Hagström E
    Lancet; 2021 Mar; 397(10279):1085-1094. PubMed ID: 33711294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.